Literature DB >> 21722343

Considering comorbidity in managing rheumatic diseases: going where trials cannot go.

Daniel Aletaha, Thomas Dörner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722343      PMCID: PMC3218897          DOI: 10.1186/ar3354

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


× No keyword cloud information.
  4 in total

Review 1.  European biologicals registers: methodology, selected results and perspectives.

Authors:  A Zink; J Askling; W G Dixon; L Klareskog; A J Silman; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2008-07-22       Impact factor: 19.103

2.  A call for pragmatic treatment trials in rheumatoid arthritis.

Authors:  Maarten Boers
Journal:  Nat Clin Pract Rheumatol       Date:  2008-04-29

Review 3.  New therapies for treatment of rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Marcus Koeller; Michael H Weisman; Paul Emery
Journal:  Lancet       Date:  2007-12-01       Impact factor: 79.321

Review 4.  Treating rheumatic patients with a malignancy.

Authors:  Katarzyna Elandt; Daniel Aletaha
Journal:  Arthritis Res Ther       Date:  2011-06-29       Impact factor: 5.156

  4 in total
  1 in total

1.  Comorbidities and multimorbidity in rheumatic diseases.

Authors:  Anna Filipowicz-Sosnowska
Journal:  Reumatologia       Date:  2019-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.